Add to ORKGNovel approaches against pancreatic cancer based on adenoviral targeting and tumor ablation. Preclinical evaluation of antitumor efficacy. Memòria presentada pe
Pancreatic ductal adenocarcinoma (PDAC) occurs in the majority of cases with early locoregional spre...
Pancreatic ductal adenocarcinoma (PDAC) occurs in the majority of cases with early locoregional spre...
Pancreatic cancer (PC) remains one of the worst cancers, with almost uniform lethality. PC risk is a...
Els tractaments actuals pel càncer de pàncreas presenten un eficàcia limitada de manera que es neces...
Pancreatic ductal adenocarcinoma (PDAC) is rare and difficult to treat, making it a complicated diag...
The recent elucidation both of the mechanisms involved in pancreatic cancer carcinogenesis and the r...
The recent elucidation both of the mechanisms involved in pancreatic cancer carcinogenesis and the r...
Pancreatic cancer is the third leading cause of cancer related death and by 2030, it will be second ...
Pancreatic cancer is one of the most lethal malignancies in the world. The incidence of pancreatic c...
Pancreatic cancer is a highly aggressive and lethal cancer characterized by high invasiveness, local...
Pancreatic adenocarcinoma carries a devastating prognosis. For locally advanced and metastatic disea...
Pancreatic adenocarcinoma is a leading cause of cancer death in western countries. The treatment of ...
Pancreatic cancer is a lethal disease and remains one of the most resistant cancers to traditional t...
Abstract | The identification of key signalling pathways involved in immune-system regulation, along...
Pancreatic cancer is one of the leading causes of cancer-related death worldwide. This is due to del...
Pancreatic ductal adenocarcinoma (PDAC) occurs in the majority of cases with early locoregional spre...
Pancreatic ductal adenocarcinoma (PDAC) occurs in the majority of cases with early locoregional spre...
Pancreatic cancer (PC) remains one of the worst cancers, with almost uniform lethality. PC risk is a...
Els tractaments actuals pel càncer de pàncreas presenten un eficàcia limitada de manera que es neces...
Pancreatic ductal adenocarcinoma (PDAC) is rare and difficult to treat, making it a complicated diag...
The recent elucidation both of the mechanisms involved in pancreatic cancer carcinogenesis and the r...
The recent elucidation both of the mechanisms involved in pancreatic cancer carcinogenesis and the r...
Pancreatic cancer is the third leading cause of cancer related death and by 2030, it will be second ...
Pancreatic cancer is one of the most lethal malignancies in the world. The incidence of pancreatic c...
Pancreatic cancer is a highly aggressive and lethal cancer characterized by high invasiveness, local...
Pancreatic adenocarcinoma carries a devastating prognosis. For locally advanced and metastatic disea...
Pancreatic adenocarcinoma is a leading cause of cancer death in western countries. The treatment of ...
Pancreatic cancer is a lethal disease and remains one of the most resistant cancers to traditional t...
Abstract | The identification of key signalling pathways involved in immune-system regulation, along...
Pancreatic cancer is one of the leading causes of cancer-related death worldwide. This is due to del...
Pancreatic ductal adenocarcinoma (PDAC) occurs in the majority of cases with early locoregional spre...
Pancreatic ductal adenocarcinoma (PDAC) occurs in the majority of cases with early locoregional spre...
Pancreatic cancer (PC) remains one of the worst cancers, with almost uniform lethality. PC risk is a...